Mar. 19 at 1:23 PM
$SDGR Question: If SDGR's Predictive Tox Screen is so great, why couldn't it predict that their proprietary SGR-2921 CDC7 inhibitor would kill two patients?
Ramy's whole premise is that using their own tools on their own programs PROVES the story for the wider community and yet their own experience proves just the opposite, that the tools are limited, at best.
I don't think I've ever heard Ramy give a full account of what went wrong here. Did this massive failure of predictive tox for their own product result in building in a better screen for everyone else? If so, HOW exactly? Where was the failure point? How did they address it?
Ramy spouted total bullshit at the KeyBanc Healthcare Forum. I swear at times he sounded completely incoherent to me.
